Stig Hansen, Kimia Therapeutics CEO

Ex­clu­sive: Kimia Ther­a­peu­tics se­cures $55M to su­per­charge co-founder’s plat­form, cre­ate ‘next-gen­er­a­tion Car­mot’

Stig Hansen and his team are look­ing to repli­cate the suc­cess they had with Car­mot Ther­a­peu­tics, but un­der a dif­fer­ent name with the same mean­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.